MedPath
FDA Approval

Sucralfate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Chartwell RX, LLC
DUNS: 079394054
Effective Date
March 16, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Sucralfate(1 g in 1 1)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sucralfate

Product Details

NDC Product Code
62135-436
Application Number
ANDA074415
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
March 16, 2023
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
POVIDONEInactive
Code: FZ989GH94EClass: IACT
Code: XX73205DH5Class: ACTIBQuantity: 1 g in 1 1
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
© Copyright 2025. All Rights Reserved by MedPath